Clinical Trial Update: Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Adebrelimab (PD-L1) with short-course radiotherapy and chemotherapy as neoadjuvant treatment for locally advanced rectal cancer is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Feng Tian | Conditions: Rectal Cancer, Advanced Stage Colorectal Cancer | Phase 2 | Status: RECRUITING